Current Ratio of Prelude Therapeutics Inc from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Prelude Therapeutics Inc quarterly Current Ratio in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • Prelude Therapeutics Inc Current Ratio for the quarter ending 30 Sep 2025 was 442%, a 52% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Prelude Therapeutics Inc Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 442% -476% -52% 30 Sep 2025
Q2 2025 532% -545% -51% 30 Jun 2025
Q1 2025 635% -674% -51% 31 Mar 2025
Q4 2024 766% -466% -38% 31 Dec 2024
Q3 2024 917% -274% -23% 30 Sep 2024
Q2 2024 1077% -32% -2.9% 30 Jun 2024
Q1 2024 1308% +222% +20% 31 Mar 2024
Q4 2023 1231% -33% -2.6% 31 Dec 2023
Q3 2023 1191% -242% -17% 30 Sep 2023
Q2 2023 1110% -501% -31% 30 Jun 2023
Q1 2023 1086% -689% -39% 31 Mar 2023
Q4 2022 1264% -753% -37% 31 Dec 2022
Q3 2022 1433% -728% -34% 30 Sep 2022
Q2 2022 1611% -734% -31% 30 Jun 2022
Q1 2022 1775% 31 Mar 2022
Q4 2021 2017% 31 Dec 2021
Q3 2021 2161% 30 Sep 2021
Q2 2021 2345% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.